Takeda’s ‘breakthrough’ Velcade heir wins early FDA approval in myeloma

Damian Garde

Takeda Pharmaceutical's top cancer prospect won a speedy FDA , wading into a crowded market for multiple treatments with hopes of duplicating the success of .

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS